Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
The Journal of Infectious Diseases|August 30, 2007
New tuberculosis therapeutics: a growing pipelineMelvin K SpigelmanRespirology (Carlton, Vic.)|June 16, 2010
Current development and future prospects in chemotherapy of tuberculosisEric L Nuermberger, Melvin K Spigelman, Wing Wai YewAntimicrobial Agents and Chemotherapy|June 17, 2009
Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjectsAnn M Ginsberg, Martino W Laurenzi, Doris J Rouse, et al.Antimicrobial Agents and Chemotherapy|March 21, 2012
Phase II dose-ranging trial of the early bactericidal activity of PA-824Andreas H Diacon, Rodney Dawson, Jeannine du Bois, et al.Lancet (London, England)|July 26, 2012
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trialAndreas H Diacon, Rodney Dawson, Florian von Groote-Bidlingmaier, et al.Antimicrobial Agents and Chemotherapy|May 26, 2010
Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patientsAndreas H Diacon, Rodney Dawson, Madeleine Hanekom, et al.Pageof 1